Brazilian drugmaker Hypera cuts 2020 revenue outlook
July 24 (Reuters) - Brazilian drugmaker Hypera SA HYPE3.SA cut its guidance for 2020 revenue on Friday, citing the effects of the novel coronavirus pandemic and the digestion of recent acquisitions.
In a securities filing, the company said it is now predicting 2020 net revenue of 4 billion reais ($764 million), down from a projection in March of 4.25 to 4.35 billion reais.
($1 = 5.23 reais)
(Reporting by Gram Slattery; Editing by Sandra Maler)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.